Importance of gated imaging in both phases of myocardial perfusion SPECT: Myocardial stunning after dipyridamole infusion

Journal of Nuclear Medicine Technology

Volumn 34, Issue 2, 2006, Pages 88-91

  Kakhki, Vahidreza Dabbagh ^a   Zakavi, Seyed Rasoul ^a   Sadeghi, Ramin ^a   Yousefi, Ahmad ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dipyridamole; Gated SPECT; Myocardial perfusion; Myocardial stunning

Indexed keywords

DIPYRIDAMOLE; GLYCERYL TRINITRATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

AGED; ARTICLE; CARDIOVASCULAR RISK; CASE REPORT; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; GATED IMAGING; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE PERFUSION; HEART VENTRICLE WALL MOTION; HUMAN; MYOCARDIAL DISEASE; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 34250674902     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hale SL, Kloner RA. Acetaminophen and myocardial stunning after transient ischemia in rabbit hearts. J Cardiovasc Pharmacol Ther. 2005;10:121-129.
2. Bestetti A, DiLeo C, Alessi A, Triulzi A, Tagliabue L, Tarolo GL. Post-stress end-systolic left ventricular dilation: a marker of endocardial post-ischemic stunning. Nucl Med Commun. 2001;22:685-693.
3. Ben-Haim S, Gips S, Merdler A, Front A, Tamir A. Myocardial stunning demonstrated with rest and post-stress measurements of left ventricular function using dual-isotope gated myocardial perfusion SPECT. Nucl Med Commun. 2004;25:657-663.
4. Sharir T, Germano G, Kavanagh PB, et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation. 1999; 100:1035-1042.
5. Kloner RA. Myocardial stunning. Lancet. 1993;341:1323-1325.
6. Mut F, Beretta M, Vidal I, et al. Identification of myocardial stunning by means of gated perfusion SPECT in patients undergoing ischaemic stress myocardial tests. World J Nucl Med. 2003;2:122-125.
7. Tonkin A, Chan R. Reperfusion injury, stunning and myocardial viability. Aust N Z J Med. 1993;23:756-759.
8. Rinaldi CA, Hall RJ. Myocardial stunning and hibernation in clinical practice. Int J Clin Pratt. 2000;54:659-664.
9. Ambrosio G, Tritto I. Clinical manifestation of myocardial stunning. Coron Artery Dis. 2001;12:357-361.
10. Barnes E, Dutka DP, Khan M, Camici PG, Hall RJ. Effect of repeated episodes of reversible myocardial ischemia on myocardial blood flow and function in humans. Am J Physiol Heart Circ Physiol. 2002;282:H1603-H1608.
11. Otto AC, van Staden J, van Aardt A, van Aswegen E, Joubert G, Englebrecht H. Evaluation of exercise-induced stunning using myocardial perfusion imaging. Cardiovasc J S Afr. 2001;12:259-262.
12. Dakik HA, Alam S. Myocardial stunning induced and detected by adenosine stress perfusion imaging. J Nucl Cardiol. 2001;8:711-712.
13. Barnes E, Hall RJ, Dutka DP, Camici PG. Absolute blood flow and oxygen consumption in stunned myocardium in patients with coronary artery disease. J Am Coll Cardiol. 2002;39:420-427.
14. Kraitchman DL, Hillenbrand HB, Oznur I, et al. Noninvasive assessment of myocardial stunning from short-term coronary occlusion using tagged magnetic resonance imaging. J Cardiovasc Magn Reson. 2000;2:123-126.
15. Beretta M, Rener A, Vidal I, et al. Demonstration of myocardial stunning after dipyridamole stress test with gated perfusion SPECT [abstract]. J Nucl Cardiol. 2001;8(suppl):S77.
16. Bestetti A, Scalzi PB, Alessi A, et al. Detection and assessment of myocardial stunning with perfusion tomographic scintigraphy using gated SPECT. Ital Heart J Suppl. 2000;1:790-796.
17. Hung GU, Chen CP, Yang KT. Incremental value of ischemic stunning on the detection of severe and extensive coronary artery disease in dipyridamole Tl-201 gated myocardial perfusion imaging. Int J Cardiol. 2005;105:108-110.
18. Pepine CJ, Feldman RL, Ludbrook P, et al. Left ventricular dyskinesia reversed by intravenous nitroglycerin: a manifestation of silent myocardial ischemia. Am J Cardiol. 1986;58:38B-42B.
19. Sawada H, Fujii J, Kuboki M, et al. Evaluation of regional wall motion of left ventricle before and after nitroglycerin administration in patients with ischemic heart disease: comparison between two-dimensional echocardiograms and angiograms. J Cardiogr. 1982;12:905-914.
20. Pfisterer M, Glaus L, Burkart F. Comparative effects of nitroglycerin, nifedipine and metoprolol on regional left ventricular function in patients with one-vessel coronary disease. Circulation. 1983;67:291-301.